Seeking Alpha

StemCells, Inc. (STEM)

  • LaboMedic | Send Message 22 Dec 2014

    $STEM Maxim Maintains Buy On StemCells Following Pathway Phase II Update
      • Life Sciences Report | Send Message 4 Dec 2014

        "There is extraordinary upside potential in $STEM"-Chris James. Read More:
          • Tom Franey | Send Message 10 Nov 2014

            StemCells Inc. Faces Tough Times Ahead $STEM
              • Biotech Research Group | Send Message 7 Nov 2014

                StemCells, Inc. : More Downside Risk Ahead $STEM
                  • JMY Investments | Send Message 3 Nov 2014

                    Time To Sell Advanced Cell Technology And Buy StemCells, Inc. $OCAT, $STEM
                      • LaboMedic | Send Message 7 Oct 2014

                        $STEM Maxim Group Reiterates Buy On StemCells Following Initiation Of Pathway Study
                          • Life Sciences Report | Send Message 11 Sep 2014

                            " $STEM will be first to initiate a controlled study using human neural stem cells"-Christopher James.
                              • Life Sciences Report | Send Message 28 Aug 2014

                                "Results from $STEM's Phase 1/2 dry AMD trial are compelling"-Jolene Furdek. Read more:
                                Reply (1)
                                • csymalla | Send Message 11 Sep 2014
                                  : compelling to start phase II not cure dry amd or even stop it.
                                  • JKenser | Send Message 20 Aug 2014

                                    $STEM, appears to be in big trouble here..
                                    Reply (1)
                                    • frommissouri | Send Message 25 Aug 2014
                                      : It is not going well for #STEM. There are allegations related to CIRM and the Trounson hiring and the employee law suit may alert FDA.
                                      • JMY Investments | Send Message 15 Aug 2014

                                        StemCells, Inc: Short-Term Noise Creates Another Buying Opportunity $STEM
                                          Visit Seeking Alpha's
                                          STEM vs. ETF Alternatives
                                          Company Description
                                          StemCells, Inc. is engaged in the research, development, and commercialization of stem cell therapeutics and related enabling technologies.
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States